| Literature DB >> 30569366 |
Kamila Kalinowska1, Sindy Chamas2, Katharina Unkel3, Dmitri Demidov2, Inna Lermontova2, Thomas Dresselhaus1, Jochen Kumlehn2, Frank Dunemann3, Andreas Houben4.
Abstract
The ability to generate (doubled) haploid plants significantly accelerates the crop breeding process. Haploids have been induced mainly through the generation of plants from cultivated gametophic (haploid) cells and tissues, i.e., in vitro haploid technologies, or through the selective loss of a parental chromosome set upon inter- or intraspecific hybridization. Here, we focus our review on the mechanisms responsible for the in vivo formation of haploids in the context of inter- and intraspecific hybridization. The application of a modified CENH3 for uniparental genome elimination, the IG1 system used for paternal as well as the BBM-like and the patatin-like phospholipase essential for maternal haploidy induction are discussed in detail.Entities:
Mesh:
Year: 2018 PMID: 30569366 PMCID: PMC6439148 DOI: 10.1007/s00122-018-3261-9
Source DB: PubMed Journal: Theor Appl Genet ISSN: 0040-5752 Impact factor: 5.699
Fig. 1Overview of methods for haploid induction in plants. In vitro methods for haploid induction involve the cultivation of male or female gametophytic cells derived from immature anthers (paternal haploids) and ovaries/ovules (maternal haploids), respectively. In vivo induction of maternal haploids can be initiated by pollination with pollen of the same species (intraspecific hybridization), where classical haploidy inducers or plants carrying mutations within CENH3 are typically used. Pollination with pollen of a wild relative or unrelated species is named as interspecific or wide hybridization. Parthenogenesis was also reported in plants treated with hormones or after genetic manipulations. Haploidy may also occur after pollination with (defective) pollen treated by radiation, chemicals or at high temperature. In some in situ methods where the development of endosperm does not take place, embryo rescue is required. Haploid embryos or seedlings undergo spontaneous genome duplication or are treated with a microtubule-blocking agent such as colchicine to induce the reduplication of the haploid genome and the generation of doubled haploid plants
Fig. 2Schematic presentation of the two different strategies to create ‘haploidy inducer’ genotypes through manipulation of CENH3
Survey of CENH3 modifications used to induce the formation of haploid plants
| Haploidy inducer plants | Progeny | References | |||
|---|---|---|---|---|---|
|
|
|
|
|
| |
|
| |||||
| T-DNA-interrupted cenh3 | GFP-H3N-tail-CENH3 HFD on T-DNA | Homozygous | 34%/4% | 32%/11% | Ravi and Chan ( |
| T-DNA-interrupted cenh3 | GFP-CENH3 on T-DNA | Homozygous | 5%/0% | 29%/4% | |
| T-DNA-interrupted cenh3 | CENH3 P82S in HFD, on T-DNA | Homozygous | 2.5%/– | – | Kuppu et al. ( |
| T-DNA-interrupted cenh3 | CENH3 G83E in HFD, on T-DNA | Homozygous | 10.5%/– | – | |
| T-DNA-interrupted cenh3 | CENH3 A86V in HFD, on T-DNA | Homozygous | 3.9%/– | – | |
| T-DNA-interrupted cenh3 | CENH3 P102S in HFD, on T-DNA | Homozygous | 0%/– | – | |
| T-DNA-interrupted cenh3 | CENH3 A132T in HFD, on T-DNA | Homozygous | 0.6%/– | – | |
| T-DNA-interrupted cenh3 | CENH3 A136Tin HFD, on T-DNA | Homozygous | 2.3%/– | – | |
| T-DNA-interrupted cenh3 | CENH3 G173E in HFD, on T-DNA | Homozygous | 0%/– | – | |
| WT | CENH3 A86V in HFD, EMS-induced | Homozygous | 2.7%/– | – | |
| T-DNA-interrupted cenh3 | CENH3 L130F in HFD, on T-DNA | Homozygous | 4.8%/0% | 8.4%/2.5% | Karimi-Ashtiyani et al. ( |
|
| |||||
| WT | L92F in HFD of ß-CENH3, EMS-induced | Homozygous | 0%/0% | – | Karimi-Ashtiyani et al. ( |
|
| |||||
| CenH3 RNAi | GFP-H3N-tail-CENH3 HFD, on T-DNA | Homozygous | like WT/0.24 (max. 2.4)% | – | Kelliher et al. ( |
| CenH3 RNAi | GFP-CENH3, on T-DNA | Homozygous | like WT (max. 1.2)%/0% | – | |
| Transposon-interrupted cenH3 | GFP-H3N-tail-CENH3 HFD, on T-DNA | Hemizygous | 0.2%/0.86 (max. 3.6)% | 1%/– | |
| Transposon-interrupted cenH3 | GFP-CENH3, on T-DNA | Hemizygous | 0.15%/0.32 (max 1.2)% | 0%/– | |
| Transposon-interrupted cenH3 | GFP-H3N-tail-CENH3 HFD, on T-DNA | Homozygous | 0.13 (max. 1.2)%/0.13 (max.1.2)% | 0%/– | |
| Transposon-interrupted cenH3 | GFP-CENH3, on T-DNA | Homozygous | 0.12 (max. 1.2)%/0.15 (max. 1.2)% | 0%/– | |
|
| |||||
| WT | K9E in N-tail, EMS-induced | Homozygous | 0.2%/2.3% | 0.2%/0% | WO 2017 200386/KEYGENE |
|
| |||||
| WT | CenH3 (K9E in N-tail), EMS-induced | Homozygous | 1%/– | – | WO 2017 200386/KEYGENE |
| WT | CenH3 (P16S in N-tail), EMS-induced | Homozygous | 0.3%/– | – | |
| WT | CenH3 (P26L in N-tail), EMS-induced | Homozygous | 0.7%/– | – | |
|
| |||||
| WT | Premature STOP in HFD, EMS-induced | Hemizygous | 1%/– | – | WO 2017 081011 A1/RIJK ZWAAN |
|
| |||||
| WT | CenH3 (D115V in HFD), EMS-induced | Homozygous | 1.5%/– | – | WO 2017 081011 A1/RIJK ZWAAN |
f female; m male
‘–’ not tested or data not provided